37LBA Telotristat etiprate is effective in treating patients with carcinoid syndrome that is inadequately controlled by somatostatin analog therapy (the phase 3 TELESTAR clinical trial)
Year: 2015
Type: article
Source: European Journal of Cancer
Authors: M.H. Kulke, D. Horsch, M. Caplin, L. Anthony, E. Bergsland, K. Oberg, S. Welin, R. Warner, C. Lombard-Bohas, P. Kunz, E. Grande, J. Valle, D. Fleming, P. Lapuerta, P. Banks, S. Jackson, D. Wheeler, B. Zambrowicz, A. Sands, M. Pavel
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2260173592